These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 33044755)
41. lncRNA GCAWKR Promotes Gastric Cancer Development by Scaffolding the Chromatin Modification Factors WDR5 and KAT2A. Ma M; Zhang Y; Weng M; Hu Y; Xuan Y; Hu Y; Lv K Mol Ther; 2018 Nov; 26(11):2658-2668. PubMed ID: 30274785 [TBL] [Abstract][Full Text] [Related]
42. AURKB promotes gastric cancer progression via activation of Nie M; Wang Y; Yu Z; Li X; Deng Y; Wang Y; Yang D; Li Q; Zeng X; Ju J; Liu M; Zhao Q Aging (Albany NY); 2020 Jan; 12(2):1304-1321. PubMed ID: 31982864 [TBL] [Abstract][Full Text] [Related]
43. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation. Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747 [TBL] [Abstract][Full Text] [Related]
44. HMGA1 promotes gastric cancer growth and metastasis by transactivating SUZ12 and CCDC43 expression. Yang Q; Wang Y; Li M; Wang Z; Zhang J; Dai W; Pei M; Hong L; Xiao Y; Hu H; Li J; Lin J; Wu X; Chen Y; Huang M; Li A; Liu S; Tang W; Xiang L; Wang J Aging (Albany NY); 2021 Jun; 13(12):16043-16061. PubMed ID: 34167089 [TBL] [Abstract][Full Text] [Related]
45. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368 [TBL] [Abstract][Full Text] [Related]
46. L-Plastin Promotes Gastric Cancer Growth and Metastasis in a Teng YS; Chen WY; Yan ZB; Lv YP; Liu YG; Mao FY; Zhao YL; Peng LS; Cheng P; Duan MB; Chen W; Wang Y; Luo P; Zou QM; Chen J; Zhuang Y Mol Cancer Res; 2021 Jun; 19(6):968-978. PubMed ID: 33771880 [TBL] [Abstract][Full Text] [Related]
47. SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway. Han S; Zhen W; Guo T; Zou J; Li F J Exp Clin Cancer Res; 2020 Oct; 39(1):218. PubMed ID: 33059737 [TBL] [Abstract][Full Text] [Related]
48. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. Zheng L; Qi T; Yang D; Qi M; Li D; Xiang X; Huang K; Tong Q PLoS One; 2013; 8(1):e55719. PubMed ID: 23383271 [TBL] [Abstract][Full Text] [Related]
49. An Overview of Matrix Metalloproteinase 9 Polymorphism and Gastric Cancer Risk. Verma S; Kesh K; Gupta A; Swarnakar S Asian Pac J Cancer Prev; 2015; 16(17):7393-400. PubMed ID: 26625734 [TBL] [Abstract][Full Text] [Related]
50. Autophagy impairment by Helicobacter pylori-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis. Muhammad JS; Nanjo S; Ando T; Yamashita S; Maekita T; Ushijima T; Tabuchi Y; Sugiyama T Int J Cancer; 2017 May; 140(10):2272-2283. PubMed ID: 28214334 [TBL] [Abstract][Full Text] [Related]
51. Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c. Zhou X; Chen H; Zhu L; Hao B; Zhang W; Hua J; Gu H; Jin W; Zhang G Oncotarget; 2016 Dec; 7(50):82770-82782. PubMed ID: 27835575 [TBL] [Abstract][Full Text] [Related]
52. Direct regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells. Peng Y; Zhang P; Huang X; Yan Q; Wu M; Xie R; Wu Y; Zhang M; Nan Q; Zhao J; Li A; Xiong J; Ren Y; Bai Y; Chen Y; Liu S; Wang J Cell Death Dis; 2016 Nov; 7(11):e2480. PubMed ID: 27882939 [TBL] [Abstract][Full Text] [Related]
53. SETDB1 promotes progression through upregulation of SF3B4 expression and regulates the immunity in ovarian cancer. Yang H; Sui L; Cai C; Chu H; Diao Y J Ovarian Res; 2024 Feb; 17(1):34. PubMed ID: 38317200 [TBL] [Abstract][Full Text] [Related]
54. TACC3 Promotes Gastric Carcinogenesis by Promoting Epithelial-mesenchymal Transition Through the ERK/Akt/cyclin D1 Signaling Pathway. Akanda MR; Park JS; Noh MG; Ha GH; Park YS; Lee JH; Moon KS; Kim CK; Lee KH Anticancer Res; 2021 Jul; 41(7):3349-3361. PubMed ID: 34230131 [TBL] [Abstract][Full Text] [Related]
55. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target. Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878 [TBL] [Abstract][Full Text] [Related]
56. MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2. Kang DW; Yang ES; Noh YN; Hwang WC; Jo SY; Suh YA; Park WS; Choi KY; Min DS J Pathol; 2017 Apr; 241(5):614-625. PubMed ID: 28008607 [TBL] [Abstract][Full Text] [Related]
57. Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway. Ou Y; Ren H; Zhao R; Song L; Liu Z; Xu W; Liu Y; Wang S Mol Carcinog; 2019 Aug; 58(8):1427-1437. PubMed ID: 31162747 [TBL] [Abstract][Full Text] [Related]
58. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma. Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365 [TBL] [Abstract][Full Text] [Related]
59. Stanniocalcin‑1 promotes cell proliferation, chemoresistance and metastasis in hypoxic gastric cancer cells via Bcl‑2. Wang Y; Qi Z; Zhou M; Yang W; Hu R; Li G; Ma X; Zhang Z Oncol Rep; 2019 Mar; 41(3):1998-2008. PubMed ID: 30747219 [TBL] [Abstract][Full Text] [Related]
60. IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9. Huang Q; Lan F; Wang X; Yu Y; Ouyang X; Zheng F; Han J; Lin Y; Xie Y; Xie F; Liu W; Yang X; Wang H; Dong L; Wang L; Tan J Mol Cancer; 2014 Jan; 13():18. PubMed ID: 24479681 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]